Effect of in vivo administration of anti-CLTA-4 mAb and stimulatory anti-CD40 mAb on the induction of low dose oral tolerance

被引：0
|
作者：
Burns, R [1 ]
Rappold, K [1 ]
机构：
[1] Thomas More Coll, Crestview Hills, KY 41017 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A949 / A949
页数：1
相关论文
共 50 条
  • [31] Tolerance induction to xenogeneic islets by anti-CD154 mAb and rapamycin is based on anergy and regulation
    Mai, G
    Andres, A
    Morel, P
    Mei, J
    Bosco, D
    Toso, C
    Berney, T
    Heusser, C
    Bigenzahn, S
    Wekerle, T
    Bühler, L
    XENOTRANSPLANTATION, 2005, 12 (05) : 387 - 387
  • [32] Effect of anti-CTLA-4 and anti-B7.2 administration on the induction of oral tolerance
    Barone, KS
    Benjamin, H
    Karlosky, L
    FASEB JOURNAL, 2001, 15 (04): : A367 - A367
  • [33] In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance
    da Cunha, Andre P.
    Wu, Henry Y.
    Rezende, Rafael M.
    Vandeventer, Tyler
    Weiner, Howard L.
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (02) : 73 - 82
  • [34] IL-12-independent down-regulation of allergic airway inflammation in mice by agonistic anti-CD40 mAb
    Hellings, PW
    Kasran, A
    Overbergh, L
    Mathieu, C
    Boon, L
    Heremans, H
    Matthys, P
    Ceuppens, JL
    ALLERGY, 2002, 57 : 134 - 134
  • [35] Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-α
    Lum, Hillary D.
    Buhtoiarov, Ilia N.
    Schmidt, Brian E.
    Berke, Gideon
    Paulnock, Donna M.
    Sondel, Paul M.
    Rakhmilevich, Alexander L.
    IMMUNOLOGY, 2006, 118 (02) : 261 - 270
  • [36] CFZ533: Assessment of Immunomodulatory Activity Following Single Doses of a Novel Anti-CD40 mAb in Healthy Volunteers
    Slade, A.
    Doucet, J.
    Koo, P.
    Espie, P.
    Rush, J.
    Tomek, C.
    Klupp, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [37] Inhibitory IgG Receptor-Expressing Cells: The Must-Have Accessory for Anti-CD40 Immunomodulatory mAb Efficacy
    Bruhns, Pierre
    Teillaud, Jean-Luc
    CANCER CELL, 2016, 29 (06) : 771 - 773
  • [38] Immunosuppression by a novel Anti-CD40 mAb, 4D11, is not arogated by combined treatment with tacrolimus for renal transplantation in cynomolgus monkeys.
    Uno, Motohiro
    Suzuki, Tomomi
    Aoyagi, Takeshi
    Sugitani, Atsushi
    Goto, Ryoichi
    Yamashita, Kenichiro
    Miura, Toru
    Takahashi, Nobuaki
    Itoh, Tomoo
    Taniguchi, Masahiko
    Shimamura, Tsuyoshi
    Furukawa, Hiroyuki
    Todo, Satoru
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 202 - 202
  • [39] In vitro and in vivo testing of an anti-CD40mAb clone, 2C10, in xenotransplantation
    Satyananda, Vikas
    Lee, Whayoung
    Iwase, Hayato
    Nagaraju, Santosh
    Tanaka, Takayuki
    Miyagawa, Yuko
    Long, Cassandra
    Reimann, Keith
    Ayares, David
    Cooper, David K. C.
    Hara, Hidetaka
    XENOTRANSPLANTATION, 2013, 20 (05) : 327 - 327
  • [40] Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody
    Taylor, PA
    Panoskaltsis-Mortari, A
    Noelle, RJ
    Blazar, BR
    JOURNAL OF IMMUNOLOGY, 2000, 164 (02): : 612 - 622
12345